These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16673275

  • 1. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
    Brière JB.
    Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
    [Abstract] [Full Text] [Related]

  • 2. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
    De Stefano V, Teofili L, Leone G, Michiels JJ.
    Semin Thromb Hemost; 1997 Apr; 23(5):411-8. PubMed ID: 9387199
    [Abstract] [Full Text] [Related]

  • 3. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis.
    Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, Guilmin F, Kiladjian JJ, Plessier A, Denninger MH, Casadevall N, Valla D, Brière JB.
    Br J Haematol; 2005 May; 129(4):553-60. PubMed ID: 15877740
    [Abstract] [Full Text] [Related]

  • 4. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis.
    Goulding C, Uttenthal B, Foroni L, Duke V, Traore A, Kottaridis P, Hoffbrand AV, Patch D, McNamara C.
    Int J Lab Hematol; 2008 Oct; 30(5):415-9. PubMed ID: 19046316
    [Abstract] [Full Text] [Related]

  • 5. [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases].
    Cobo F, Cervantes F, García-Pagán JC, Bosch J, Rozman C, Montserrat E.
    Med Clin (Barc); 1996 Nov 16; 107(17):660-3. PubMed ID: 9064408
    [Abstract] [Full Text] [Related]

  • 6. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
    Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D.
    Hepatology; 2000 Mar 16; 31(3):587-91. PubMed ID: 10706547
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
    Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL.
    Am J Gastroenterol; 2006 Jan 16; 101(1):83-90. PubMed ID: 16405538
    [Abstract] [Full Text] [Related]

  • 8. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
    Ulrich F, Pratschke J, Neumann U, Pascher A, Puhl G, Fellmer P, Weiss S, Jonas S, Neuhaus P.
    Liver Transpl; 2008 Feb 16; 14(2):144-50. PubMed ID: 18236386
    [Abstract] [Full Text] [Related]

  • 9. In vitro colony culture and chromosomal studies in hepatic and portal vein thrombosis--possible evidence of an occult myeloproliferative state.
    Pagliuca A, Mufti GJ, Janossa-Tahernia M, Eridani S, Westwood NB, Thumpston J, Sawyer B, Sturgess R, Williams R.
    Q J Med; 1990 Sep 16; 76(281):981-9. PubMed ID: 2236481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
    Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell'Era A, Bucciarelli P, Mannucci PM.
    Hepatology; 2006 Dec 16; 44(6):1528-34. PubMed ID: 17133457
    [Abstract] [Full Text] [Related]

  • 12. The role of thrombophilia in splanchnic vein thrombosis.
    Primignani M, Mannucci PM.
    Semin Liver Dis; 2008 Aug 16; 28(3):293-301. PubMed ID: 18814082
    [Abstract] [Full Text] [Related]

  • 13. Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies.
    Kiladjian JJ, Cassinat B.
    Am J Hematol; 2023 May 16; 98(5):794-800. PubMed ID: 36869873
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prothrombotic disorders in abdominal vein thrombosis.
    Leebeek FW, Smalberg JH, Janssen HL.
    Neth J Med; 2012 Nov 16; 70(9):400-5. PubMed ID: 23123534
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
    Karaköse S, Oruç N, Zengin M, Akarca US, Ersöz G.
    Turk J Gastroenterol; 2015 Jan 16; 26(1):42-8. PubMed ID: 25698270
    [Abstract] [Full Text] [Related]

  • 17. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
    Fama A, Rago A, Gioiosa F, Marzano C, Latagliata R, Mammì C, Laganà C, D'Elia GM, Bizzoni L, Trasarti S, Ferretti A, Breccia M, Riggio O, Tafuri A.
    Clin Ter; 2010 Jan 16; 161(2):169-71. PubMed ID: 20499034
    [Abstract] [Full Text] [Related]

  • 18. Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report.
    Spahr L, Cerny A, Morard I, Rubbia-Brandt L, Schrenzel J.
    BMC Gastroenterol; 2006 Mar 10; 6():10. PubMed ID: 16529659
    [Abstract] [Full Text] [Related]

  • 19. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.
    Smalberg JH, Darwish Murad S, Braakman E, Valk PJ, Janssen HL, Leebeek FW.
    Haematologica; 2006 Dec 10; 91(12):1712-3. PubMed ID: 17145613
    [Abstract] [Full Text] [Related]

  • 20. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.
    Michiels JJ, Commandeur S, Hoogenboom GJ, Wegman JJ, Scholten L, van Rijssel RH, De Raeve H.
    Ann Hematol; 2007 Nov 10; 86(11):793-800. PubMed ID: 17687555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.